Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Mats Blom — Board member

Roles

Egetis Therapeutics AB (publ) Stockholm
Board member
25.11.2025 – 14.01.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
14.01.2026Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
150,000SEK 4.48
SEK 672,000.00
↗
26.11.2025✎Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
35,000SEK 4.29
SEK 150,150.00
↗
25.11.2025✎Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
180,000SEK 5.24
SEK 943,200.00
↗